Loading...
•
Mar 31, 2024
Natera Q1 2024 Earnings Report
Driven by robust volume, revenue and margin growth, the company achieved cash flow breakeven earlier than expected.
Key Takeaways
Natera reported a strong start to the year with significant growth in volume, revenue, and margin, achieving cash flow breakeven ahead of schedule. Total revenues increased by 52.1% to $367.7 million, driven by a 53.4% increase in product revenues. The company processed approximately 735,800 tests and reported a net loss of $67.6 million, or ($0.56) per diluted share.
Total revenues increased by 52.1% to $367.7 million compared to Q1 2023.
Product revenues grew by 53.4% to $364.7 million driven by volume and average selling price improvements.
Approximately 735,800 tests were processed, including 718,700 tests accessioned in the laboratory.
Net loss for the quarter was $67.6 million, or ($0.56) per diluted share, compared to a net loss of $136.9 million in Q1 2023.
Revenue by Segment
Forward Guidance
Natera anticipates 2024 total revenue of $1.42 billion to $1.45 billion; 2024 gross margin to be approximately 53% to 55% of revenues; selling, general and administrative costs to be approximately $700 million to $750 million; research and development costs to be $350 million to $375 million, and net cash inflow (consumption) to be ($25) million to $25 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...